Table of Contents
4 relations: Antileukotriene, Arachidonate 5-lipoxygenase, Atherosclerosis, 5-lipoxygenase-activating protein.
Antileukotriene
An antileukotriene, also known as leukotriene modifier and leukotriene receptor antagonist, is a medication which functions as a leukotriene-related enzyme inhibitor (arachidonate 5-lipoxygenase) or leukotriene receptor antagonist (cysteinyl leukotriene receptors) and consequently opposes the function of these inflammatory mediators; leukotrienes are produced by the immune system and serve to promote bronchoconstriction, inflammation, microvascular permeability, and mucus secretion in asthma and COPD.
See MK-886 and Antileukotriene
Arachidonate 5-lipoxygenase
Arachidonate 5-lipoxygenase, also known as ALOX5, 5-lipoxygenase, 5-LOX, or 5-LO, is a non-heme iron-containing enzyme (EC 1.13.11.34) that in humans is encoded by the ALOX5 gene.
See MK-886 and Arachidonate 5-lipoxygenase
Atherosclerosis
Atherosclerosis is a pattern of the disease arteriosclerosis, characterized by development of abnormalities called lesions in walls of arteries.
See MK-886 and Atherosclerosis
5-lipoxygenase-activating protein
Arachidonate 5-lipoxygenase-activating protein also known as 5-lipoxygenase activating protein, or FLAP, is a protein that in humans is encoded by the ALOX5AP gene.
See MK-886 and 5-lipoxygenase-activating protein
References
Also known as L 663536, L-663,536, MK 886.